Among genetic aberrations potentially related to the development of AML or prognosis assessment among patients, changes in genes coding for the so-called transcription factors (including RUNX1, RUNX3, CEBPA, ASXL1) regulating transcription processes as well as controlling the cell differentiation and formation seem significant [4, 6]. The gene discussed is CEBPA; the disease is acute myeloid leukemia.